Perkins Coie Trust Co buys $2,615,755 stake in UnitedHealth Group Inc (UNH)

UnitedHealth Group Inc (UNH) : Perkins Coie Trust Co scooped up 312 additional shares in UnitedHealth Group Inc during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Jul 8, 2016. The investment management firm now holds a total of 18,516 shares of UnitedHealth Group Inc which is valued at $2,615,755.UnitedHealth Group Inc makes up approximately 1.70% of Perkins Coie Trust Co’s portfolio.

Other Hedge Funds, Including , Chicago Trust Co Na reduced its stake in UNH by selling 648 shares or 15.04% in the most recent quarter. The Hedge Fund company now holds 3,661 shares of UNH which is valued at $517,189. UnitedHealth Group Inc makes up approx 0.22% of Chicago Trust Co Na’s portfolio.First American Trust Fsb reduced its stake in UNH by selling 1,550 shares or 5.64% in the most recent quarter. The Hedge Fund company now holds 25,910 shares of UNH which is valued at $3,660,306. UnitedHealth Group Inc makes up approx 1.28% of First American Trust Fsb’s portfolio. Iowa State Bank added UNH to its portfolio by purchasing 449 company shares during the most recent quarter which is valued at $63,430. UnitedHealth Group Inc makes up approx 0.03% of Iowa State Bank’s portfolio.Summit Financial Wealth Advisors reduced its stake in UNH by selling 796 shares or 2.89% in the most recent quarter. The Hedge Fund company now holds 26,747 shares of UNH which is valued at $3,778,549. UnitedHealth Group Inc makes up approx 1.56% of Summit Financial Wealth Advisors’s portfolio.

UnitedHealth Group Inc opened for trading at $140.96 and hit $141.59 on the upside on Wednesday, eventually ending the session at $141.48, with a gain of 1.16% or 1.62 points. The heightened volatility saw the trading volume jump to 31,64,735 shares. Company has a market cap of $134,520 M.

On the company’s financial health, UnitedHealth Group Inc reported $1.81 EPS for the quarter, beating the analyst consensus estimate by $ 0.09 according to the earnings call on Apr 19, 2016. Analyst had a consensus of $1.72. The company had revenue of $44527.00 million for the quarter, compared to analysts expectations of $44278.96 million. The company’s revenue was up 24.5% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.46 EPS.

Many Wall Street Analysts have commented on UnitedHealth Group Inc. UnitedHealth Group Inc was Initiated by Bernstein to “Outperform” on Jun 16, 2016. Company shares were Reiterated by Mizuho on Apr 20, 2016 to “Buy”, Firm has raised the Price Target to $ 156 from a previous price target of $150 .

UnitedHealth Group Incorporated is a health and well-being company. The Company’s business platforms include UnitedHealthcare and Optum. UnitedHealthcare provides health care benefits to various customers and markets. Optum is a health services business serving the health care marketplace including payers care providers employers Governments life sciences companies and consumers. The Company’s business platforms have four segments: UnitedHealthcare OptumHealth OptumInsight and OptumRx. UnitedHealthcare includes UnitedHealthcare Employer & Individual UnitedHealthcare Medicare & Retirement UnitedHealthcare Community & State and UnitedHealthcare Global. OptumHealth is a health and wellness business serving the physical emotional and financial needs of individuals. OptumInsight provides technology operational and consulting services to participants in the health care industry. OptumRx provides a range of pharmacy benefit management (PBM) services.

Leave a Reply

UnitedHealth Group Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on UnitedHealth Group Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.